Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
12/13/2000 | EP1058726A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
12/13/2000 | EP1058500A1 The helios gene |
12/13/2000 | EP0914144B1 Therapeutic uses of bpi protein products for human meningococcemia |
12/13/2000 | EP0778781B1 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
12/13/2000 | EP0601062B2 Sirs vaccine and diagnosis method |
12/13/2000 | CN1276833A Vaccine |
12/13/2000 | CN1276830A Single-stranded antibody against hepatitis B virus core protein, gene thereof, and therapeutic agent for hepatitis B contg. these |
12/13/2000 | CN1276798A Monoclonal antibody inducing apoptosis |
12/13/2000 | CN1276729A Heparin-binding growth factor (HBGF) polypeptides |
12/13/2000 | CN1276726A Method for treating hypercoagulable states or acquired protein C deficiency |
12/13/2000 | CN1059465C Method for diagnosing disorder by determining expression of GAGE tumor rejection antigen precursors |
12/12/2000 | US6160099 Anti-human αv β3 and αv β5 antibodies |
12/12/2000 | US6160098 Preparing a fixed erythrocyte transport protein having preferential physical properties; obtain deoxygenated erythrocyte transport protein and controlling physical properties of solution during fixation |
12/12/2000 | US6160094 Enzymatic polypeptide; for use as a wound healing agent; for use in dentistry to prevent of adhesion of bacteria in wounds |
12/12/2000 | US6160091 Transcription factor; for the treatment of genetic disorders; for gene therapy |
12/12/2000 | US6160089 Cellular signal for the expression of mammalian somatotropin; for the amplification of somatotropin in cells |
12/12/2000 | US6160088 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins |
12/12/2000 | US6159949 Polynucleotides, codes and amino acid sequences |
12/12/2000 | US6159947 Isolation of nucleic acids and gene codes |
12/12/2000 | US6159946 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
12/12/2000 | US6159937 Immunomodulators |
12/12/2000 | US6159936 Microbiocides or viricides |
12/12/2000 | US6159746 Solid phase immunoassay to detect inhibitors of proteolytic enzymes |
12/12/2000 | US6159729 For recombinant production and vaccines |
12/12/2000 | US6159723 Renin-active substance |
12/12/2000 | US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease |
12/12/2000 | US6159712 Methods for enhancing the production of interferon in cell culture |
12/12/2000 | US6159711 Amino acid sequences; antiinflammatory agents; treatment of asthma, allergic rhinitis or atopic dermatitis |
12/12/2000 | US6159708 Chaperone expression plasmids |
12/12/2000 | US6159704 Phosphatase modulator |
12/12/2000 | US6159700 Method of finding agonist and antagonist to human and rat GPR14 |
12/12/2000 | US6159690 Digesting parent polynucleotide with exonuclease, contacting fragments with template under annealing conditions, then amplifying to generate polynucleotides which encode protein motifs with altered characteristics; enzymes; antibodies |
12/12/2000 | US6159467 In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy |
12/12/2000 | US6159463 Lymphocyte chemoattractant factor |
12/12/2000 | CA2044721C Preparation and use of enzyme-detergent extracted streptococcus zooepidemicus vaccine |
12/12/2000 | CA2014948C Genes coding for a protein having human macif activity, expression vectors containing said genes, transformant cells and proteins having human macif activity |
12/12/2000 | CA1341152C Receptor protein for human b cell stimulatory factor-2 |
12/07/2000 | WO2000073801A2 Breast, gastric and prostate cancer associated antigens and uses therefor |
12/07/2000 | WO2000073463A1 Groel muteins with improved stability |
12/07/2000 | WO2000073460A2 Modified cytokine for its stabilisation |
12/07/2000 | WO2000073459A1 Four-helical bundle protein zsig81 |
12/07/2000 | WO2000073458A1 Secreted alpha-helical protein-31 |
12/07/2000 | WO2000073456A1 A VARIANT OF C6 β-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY |
12/07/2000 | WO2000073455A1 Biosynthesis of foreign proteins using transformed microalgae |
12/07/2000 | WO2000073453A1 T-bet compositions and methods of use thereof |
12/07/2000 | WO2000073450A2 Cytoskeleton-associated proteins |
12/07/2000 | WO2000073449A1 Dna encoding snorf33 receptor |
12/07/2000 | WO2000073448A1 Adipocyte complement related protein homolog zacrp7 |
12/07/2000 | WO2000073445A2 Interleukin-1-receptor associated kinase-3 (irak3) |
12/07/2000 | WO2000073444A1 Adipocyte complement related protein homolog zacrp5 |
12/07/2000 | WO2000073443A1 Lipid metabolism transcription factor |
12/07/2000 | WO2000073438A1 Tumor-associated antigen (c42) |
12/07/2000 | WO2000073349A1 Dr4 antibodies and uses thereof |
12/07/2000 | WO2000073348A2 Methods and compositions for inhibiting neoplastic cell growth |
12/07/2000 | WO2000073344A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
12/07/2000 | WO2000073338A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
12/07/2000 | WO2000073334A2 Human sorting nexins |
12/07/2000 | WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation |
12/07/2000 | WO2000073321A1 Human tumor necrosis factor receptor tr10 |
12/07/2000 | WO2000073319A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins |
12/07/2000 | WO2000046391A3 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
12/07/2000 | WO2000044392A3 Identification of specific differentially expressed mycobacterial antigens |
12/07/2000 | WO2000043519A3 Neisseria meningitidis polypeptides |
12/07/2000 | WO2000042561A3 Oligonucleotide mediated nucleic acid recombination |
12/07/2000 | WO2000039304A9 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
12/07/2000 | CA2414214A1 Four-helical bundle protein zsig81 |
12/07/2000 | CA2378737A1 Adipocyte complement related protein homolog zacrp5 |
12/07/2000 | CA2376133A1 Tumor-associated antigen (c42) |
12/07/2000 | CA2376116A1 Promotion or inhibition of angiogenesis and cardiovascularization |
12/07/2000 | CA2375855A1 Modulation of gene expression in gastrointestinal inflammation |
12/07/2000 | CA2375095A1 Groel muteins with improved stability |
12/07/2000 | CA2375050A1 T-bet compositions and methods of use thereof |
12/07/2000 | CA2375049A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
12/07/2000 | CA2375047A1 Dna encoding snorf33 receptor |
12/07/2000 | CA2374599A1 Dr4 antibodies and uses thereof |
12/07/2000 | CA2374412A1 Secreted alpha-helical protein-31 |
12/07/2000 | CA2374409A1 A variant of c6 .beta.-chemokine leukotactin-1(shlkn-1) with enhanced biological activity |
12/07/2000 | CA2374402A1 Biosynthesis of foreign proteins using transformed microalgae |
12/07/2000 | CA2374387A1 Adipocyte complement related protein homolog zacrp7 |
12/07/2000 | CA2374376A1 Lipid metabolism transcription factor |
12/07/2000 | CA2374222A1 Cytoskeleton-associated proteins |
12/07/2000 | CA2373915A1 Methods and compositions for inhibiting neoplastic cell growth |
12/07/2000 | CA2372566A1 Modified cytokine for its stabilisation |
12/07/2000 | CA2372246A1 Human tumor necrosis factor receptor tr10 |
12/07/2000 | CA2372243A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins |
12/07/2000 | CA2336262A1 Sorting nexins |
12/06/2000 | EP1057891A1 Use of the BNM3 transcriptional activator to control plant embryogenesis and regeneration processes |
12/06/2000 | EP1057033A1 Treating cancer |
12/06/2000 | EP1057032A2 Treating cancer |
12/06/2000 | EP1057031A1 Treating cancer |
12/06/2000 | EP1057030A2 Treating cancer |
12/06/2000 | EP1057029A2 Treating cancer |
12/06/2000 | EP1057028A1 Treating cancer |
12/06/2000 | EP1057027A2 Treating cancer |
12/06/2000 | EP1056869A2 Cell cycle related proteins |
12/06/2000 | EP1056858A1 RECOMBINANT ACTIVE HUMAN ZONA PELLUCIDA PROTEIN 3 (hZP3) |
12/06/2000 | EP1056857A2 Transporter for saccharide-coupled medicaments |
12/06/2000 | EP1056855A2 Exo1 and exo2, exocytotic proteins |
12/06/2000 | EP1056853A2 Human channel-related molecules |
12/06/2000 | EP1056849A1 Human smn-like protein |